Cytek Biosciences Inc. (CTKB)

AI Score

Unlock

3.65

-0.02 (-0.54%)

At close: Apr 17, 2025, 3:59 PM

3.65

0.00%

After-hours: Apr 17, 2025, 04:35 PM EDT

Cytek Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	33.65M	51.5M	46.62M	44.86M	58.23M	48M	49.69M	37.09M	48.34M	40.48M	40.16M	35.06M	38.89M	34.38M	30.41M	24.27M	30.62M	25.1M	19.14M	17.99M
Cost of Revenue	n/a	22.5M	21.18M	21.85M	25.18M	20.82M	21.53M	16.05M	18.96M	13.62M	15.6M	14.89M	15.26M	12.99M	10.66M	9.79M	11.17M	9.48M	10.87M	9.61M
Gross Profit	33.65M	29M	25.44M	23.01M	33.05M	27.18M	28.16M	21.04M	29.37M	26.86M	24.56M	20.18M	23.64M	21.39M	19.75M	14.49M	19.45M	15.62M	8.27M	8.38M
Operating Income	2.99M	-4.25M	-8.53M	-10.73M	-137K	-6.42M	-9.13M	-12.16M	84K	2.5M	-891K	-2.36M	1.33M	3.07M	3.81M	1.13M	7.88M	6.71M	-218K	-710K
Interest Income	6.15M	1.43M	1.42M	1.36M	1.45M	1.62M	1.2M	2.14M	2.63M	1.58M	391K	18K	18K	12K	9K	10K	5K	3K	16K	86K
Pretax Income	10.32M	157K	-7.19M	-8.99M	4.11M	-4.18M	-6.59M	-9.04M	4.11M	1.85M	-1.4M	-3.3M	454K	2.25M	3.27M	152K	8M	6.9M	192K	-661K
Net Income	9.64M	941K	-10.43M	-6.17M	5.5M	-6.46M	-4.39M	-6.81M	3.53M	1.67M	-598K	-2.16M	225K	1.59M	2.67M	102K	5.6M	6.54M	8.11M	-839K
Selling & General & Admin	20.94M	23.37M	23.96M	23.95M	22.32M	22.43M	25.15M	23.23M	19.54M	16.85M	17.02M	14.51M	15.23M	12.24M	9.74M	8.26M	7.19M	5.53M	5.57M	6.07M
Research & Development	9.72M	9.88M	10M	9.8M	10.87M	11.17M	12.14M	9.97M	9.75M	8.65M	8.44M	8.03M	7.08M	6.08M	6.19M	5.09M	4.38M	3.38M	2.92M	3.02M
Other Expenses	n/a	n/a	59K	823K	3.19M	1.21M	1.74M	1.65M	n/a	-445K	-254K	-374K	-399K	-393K	-120K	-615K	451K	185K	395K	-37K
Operating Expenses	30.67M	33.25M	33.96M	33.75M	33.19M	33.6M	37.29M	33.2M	29.29M	25.5M	25.45M	22.53M	22.31M	18.31M	15.93M	13.35M	11.57M	8.9M	8.49M	9.09M
Interest Expense	-694K	119K	134K	441K	394K	595K	409K	673K	687K	649K	647K	590K	492K	441K	433K	375K	330K	2K	1K	n/a
Selling & Marketing Expenses	11.87M	12.43M	12.27M	12.54M	11.56M	12.08M	14.37M	11.14M	9.03M	8.81M	8.43M	6.96M	8.3M	6.33M	5.58M	4.28M	4.56M	3.84M	3.06M	3.53M
Cost & Expenses	29.26M	55.75M	55.14M	55.59M	58.37M	54.42M	58.82M	49.25M	48.25M	39.12M	41.05M	37.42M	37.57M	31.3M	26.6M	23.14M	22.74M	18.39M	19.35M	18.7M
Income Tax Expense	680K	-784K	3.25M	-2.82M	-1.39M	2.27M	-2.21M	-2.23M	396K	224K	-699K	-1.15M	203K	655K	597K	50K	2.4M	357K	-7.92M	178K
Shares Outstanding (Basic)	131M	131M	131.44M	130.92M	130.71M	136.17M	135.92M	135.49M	n/a	134.71M	134.4M	133.9M	108.32M	108.32M	130.81M	31.56M	118.83M	31.56M	31.56M	118.83M
Shares Outstanding (Diluted)	132.79M	132.79M	131.44M	130.92M	130.71M	136.17M	135.92M	135.49M	n/a	138.71M	134.4M	133.9M	113.64M	113.64M	130.81M	35.76M	123.03M	35.76M	35.76M	123.03M
EPS (Basic)	0.07	0.01	-0.08	-0.05	0.04	-0.05	-0.03	-0.05	n/a	0.01	-0.00	-0.02	0.00	0.01	0.02	0.00	0.05	0.21	0.26	-0.01
EPS (Diluted)	0.07	0.01	-0.08	-0.05	0.04	-0.05	-0.03	-0.05	n/a	0.01	-0.00	-0.02	0.00	0.01	0.02	0.00	0.05	0.18	0.23	-0.01
EBITDA	-2.45M	3.08M	-4.57M	-6.09M	2.29M	-1.03M	-4.57M	-7.37M	6.67M	3.83M	112K	-1.92M	2.23M	2.71M	3.9M	694K	8.03M	7.08M	354K	-556K
EBIT	-5.19M	276K	-7.05M	-8.55M	4.5M	-3.59M	-6.19M	-8.37M	4.8M	1.36M	-754K	-2.71M	1.55M	2.52M	3.81M	1.13M	8.33M	6.71M	193K	-661K
Depreciation & Amortization	2.74M	2.81M	2.48M	2.46M	2.42M	2.56M	1.62M	1M	1.86M	1.33M	866K	794K	685K	194K	200K	167K	158K	179K	161K	105K